Absence of interferon-gamma release assay conversion following tuberculin skin testing

International Journal of Tuberculosis and Lung Disease

Volumn 15, Issue 6, 2011, Pages

  Ritz, Nicole ^a,b   Yau, C ^a,b   Connell, T G ^a,b   Tebruegge, M ^a,b   Leslie, D ^c   Curtis, N ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

^c VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

Author keywords

Boosting; IGRA; Mantoux; PPD; Quantiferon

Indexed keywords

BACTERIAL ANTIGEN; GAMMA INTERFERON; GOLD; TUBERCULIN;

ADULT; ARTICLE; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; ENZYME ASSAY; ENZYME RELEASE; FEMALE; HUMAN; HUMAN EXPERIMENT; IMMUNOMODULATION; LUNG TUBERCULOSIS; MALE; MEDICAL STUDENT; MYCOBACTERIUM TUBERCULOSIS; NORMAL HUMAN; PRIORITY JOURNAL; TUBERCULIN TEST;

ADULT; ANTIGENS, BACTERIAL; HUMANS; IMMUNOASSAY; INTERFERON-GAMMA; MYCOBACTERIUM TUBERCULOSIS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; STUDENTS, MEDICAL; TUBERCULIN TEST; TUBERCULOSIS; YOUNG ADULT;

EID: 79955799323     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.10.0339     Document Type: Article

References (15)

1. van Zyl-Smit R N, Zwerling A, Dheda K, et al. Within-subject variability of interferon-γ assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic review. PLoS One 2009; 4: e8517.
2. Richeldi L, Bergamini B M, Vaienti F. Prior tuberculin skin testing does not boost QuantiFERON-TB results in paediatric contacts. Eur Respir J 2008; 32: 524-525.
3. Nguyen M, Perry S, Parsonnet J. QuantiFERON-TB predicts tuberculin skin test boosting in U.S. foreign-born. Int J Tuberc Lung Dis 2005; 9: 985-991. (Pubitemid 41549185)
4. Naseer A, Naqvi S, Kampmann B. Evidence for boosting M ycobacterium tuberculosis-specific IFN-gamma responses at 6 weeks following tuberculin skin testing. Eur Respir J 2007; 29: 1282-1283.
5. Leyten E M, Prins C, Bossink A W, et al. Effect of tuberculin skin testing on a Mycobacterium tuberculosis-specific interferon-gamma assay. Eur Respir J 2007; 29: 1212-1216. (Pubitemid 46895383)
6. Igari H, Watanabe A, Sato T. Booster phenomenon of Quanti- FERON-TB Gold after prior intradermal PPD injection. Int J Tuberc Lung Dis 2007; 11: 788-791. (Pubitemid 47056989)
7. Choi J C, Shin J W, Kim J Y, et al. The effect of previous tuberculin skin test on the follow-up examination of whole-blood interferon-gamma assay in the screening for latent tuberculosis infection. Chest 2008; 133: 1415-1420. (Pubitemid 351892999)
8. Perry S, Sanchez L, Yang S, et al. Reproducibility of Quanti- FERON-TB Gold In-Tube assay. Clin Vaccine Immunol 2008; 15: 425-432. (Pubitemid 351967072)
9. Baker C A, Thomas W, Stauffer W M, et al. Serial testing of refugees for latent tuberculosis using the QuantiFERON-Gold In-Tube: effects of an antecedent tuberculin skin test. Am J Trop Med Hyg 2009; 80: 628-633.
10. van Zyl-Smit R N, Pai M, Peprah K, et al. Within-subject variability and boosting of T-cell interferon-gamma responses after tuberculin skin testing. Am J Respir Crit Care Med 2009; 180: 49-58.
11. Cellestis. QuantiFERON-TB Gold (In-Tube Method): package insert. Carnegie, VIC, Australia: Cellestis, 2007.
12. National Institute for Health and Clinical Excellence, National Collaboration Centre for Chronic Conditions. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. London, UK: NICE, 2006.
13. Canadian Tuberculosis Committee. Updated recommendations on interferon gamma release assays for latent tuberculosis infection. Can Commun Dis Rep 2008; 34: 1-13.
14. Lungenliga Schweiz. Handbuch tuberkulose. Berne, Switzerland: Lungenliga, 2007.
15. Detjen A K, Loebenberg L, Grewal H M, et al. Short-term reproducibility of a commercial interferon-gamma release assay. Clin Vaccine Immunol 2009; 16: 1170-1175.